卫宁健康
(300253)
| 流通市值：130.01亿 | | | 总市值：154.31亿 |
| 流通股本：18.55亿 | | | 总股本：22.01亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 994,411,309.05 | 397,456,279.95 | 2,106,166,908.59 | 1,295,802,097.22 |
| 营业收入 | 994,411,309.05 | 397,456,279.95 | 2,106,166,908.59 | 1,295,802,097.22 |
| 二、营业总成本 | 1,139,874,224.5 | 464,227,086.2 | 2,323,174,988.34 | 1,538,894,486.85 |
| 营业成本 | 659,615,116.82 | 275,146,136.39 | 1,414,739,619.03 | 919,056,862.86 |
| 税金及附加 | 7,654,240.43 | 3,027,847.08 | 14,945,739.37 | 10,156,317.76 |
| 销售费用 | 153,153,622.35 | 51,356,578.05 | 319,760,538.72 | 205,661,234.39 |
| 管理费用 | 114,905,731.48 | 38,698,318.24 | 178,034,643.6 | 118,512,491.76 |
| 研发费用 | 172,075,034.56 | 80,501,214.58 | 333,543,196.22 | 240,826,375.62 |
| 财务费用 | 32,470,478.86 | 15,496,991.86 | 62,151,251.4 | 44,681,204.46 |
| 其中:利息费用 | 35,357,639.79 | 17,707,561.39 | 68,600,185.44 | 50,376,737.81 |
| 其中:利息收入 | 3,088,465.85 | 2,322,202.51 | 6,920,521.86 | 6,018,543.2 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -4,195,055.53 | -922,774.07 | -24,406,986.94 | -15,191,089.5 |
| 加:投资收益 | -14,854,327.55 | -7,136,990.91 | -26,099,660.2 | -19,085,260.63 |
| 资产处置收益 | 192,799.43 | 2,332.33 | 3,050,417.08 | 2,173,746.3 |
| 资产减值损失(新) | -95,347,617.54 | -3,726,883.3 | -140,857,646.94 | -61,617,061.11 |
| 信用减值损失(新) | -21,898,785.46 | 35,891,106.02 | -110,650,502.69 | -5,727,617.59 |
| 其他收益 | 52,827,402.33 | 29,312,009.63 | 97,832,804.8 | 79,559,235.85 |
| 四、营业利润 | -228,738,499.77 | -13,352,006.55 | -418,139,654.64 | -262,980,436.31 |
| 加:营业外收入 | 934.25 | 10,165.22 | 222,783.54 | 64,444.61 |
| 减:营业外支出 | 195,966.14 | 94,123.04 | 24,559,841.67 | 58,032,393.37 |
| 五、利润总额 | -228,933,531.66 | -13,435,964.37 | -442,476,712.77 | -320,948,385.07 |
| 减:所得税费用 | -35,419,051.95 | -12,096,032.52 | -58,304,238.43 | -73,188,278.12 |
| 六、净利润 | -193,514,479.71 | -1,339,931.85 | -384,172,474.34 | -247,760,106.95 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -193,514,479.71 | -1,339,931.85 | -384,172,474.34 | -247,760,106.95 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -176,397,147.97 | 14,030,859.04 | -373,882,252.65 | -241,386,078.27 |
| 少数股东损益 | -17,117,331.74 | -15,370,790.89 | -10,290,221.69 | -6,374,028.68 |
| 扣除非经常损益后的净利润 | -185,870,075.74 | 1,526,701.35 | -354,567,960.77 | -227,518,349.84 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.08 | 0.01 | -0.17 | -0.11 |
| (二)稀释每股收益 | -0.08 | 0.01 | -0.17 | -0.11 |
| 九、综合收益总额 | -193,514,479.71 | -1,339,931.85 | -384,172,474.34 | -247,760,106.95 |
| 归属于母公司股东的综合收益总额 | -176,397,147.97 | 14,030,859.04 | -373,882,252.65 | -241,386,078.27 |
| 归属于少数股东的综合收益总额 | -17,117,331.74 | -15,370,790.89 | -10,290,221.69 | -6,374,028.68 |
| 公告日期 | 2026-08-26 | 2026-04-23 | 2026-04-15 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |